Christopher O'Donnell

13PUBLICATIONS
48CO-AUTHORS
Chemical engineering designBiomolecular modelling and designBiomaterialsCheminformatics and quantitative structure-activity relationshipsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 07, 2024
Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer's Disease.

Martin Pettersson, Douglas S Johnson, John M Humphrey

|Aug 01, 2023
Synthetic Approaches to the New Drugs Approved During 2021.

Emma L McInturff, Scott P France, Carolyn A Leverett

|Jul 14, 2022
Synthetic Approaches to the New Drugs Approved During 2020.

Andrew C Flick, Carolyn A Leverett, Hong X Ding

|Jul 06, 2022
Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade.

Andrea T Hooper, Kimberly Marquette, Chao-Pei Betty Chang

|Mar 30, 2021
Synthetic Approaches to the New Drugs Approved during 2019.

Andrew C Flick, Carolyn A Leverett, Hong X Ding

|Nov 05, 2020
Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid Leukemia.

Yoon-Chi Han, Jennifer Kahler, Nicole Piché-Nicholas

Pageof 3

Frequent Collaborators

4 joint publications

Emma McInturff

3 joint publications

Christopher J Helal

3 joint publications

Scott P France

3 joint publications

Edward Rosfjord